One-Step Solid Extraction for Simultaneous Determination of Eleven Commonly Used Anticancer Drugs and One Active Metabolite in Human Plasma by HPLC-MS/MS

Therapeutic drug monitoring for anticancer drugs could timely reflect in vivo drug exposure, and it was a powerful tool for adjusting and maintaining drug concentration into a reasonable range, so that an enhanced efficacy and declined adverse reactions could be achieved. A liquid chromatography-tan...

Full description

Saved in:
Bibliographic Details
Main Authors: Shouhong Gao, Zhengbo Tao, Jingya Zhou, Zhipeng Wang, Yunlei Yun, Mingming Li, Feng Zhang, Wansheng Chen, Yejun Miao
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Analytical Methods in Chemistry
Online Access:http://dx.doi.org/10.1155/2018/7967694
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561314715664384
author Shouhong Gao
Zhengbo Tao
Jingya Zhou
Zhipeng Wang
Yunlei Yun
Mingming Li
Feng Zhang
Wansheng Chen
Yejun Miao
author_facet Shouhong Gao
Zhengbo Tao
Jingya Zhou
Zhipeng Wang
Yunlei Yun
Mingming Li
Feng Zhang
Wansheng Chen
Yejun Miao
author_sort Shouhong Gao
collection DOAJ
description Therapeutic drug monitoring for anticancer drugs could timely reflect in vivo drug exposure, and it was a powerful tool for adjusting and maintaining drug concentration into a reasonable range, so that an enhanced efficacy and declined adverse reactions could be achieved. A liquid chromatography-tandem mass spectrometry method had been developed and fully validated for simultaneous determination of paclitaxel, docetaxel, vinblastine, vinorelbine, pemetrexed, carboplatin, etoposide, cyclophosphamide, ifosfamide, gemcitabine, irinotecan, and SN-38 (an active metabolite of irinotecan) in human plasma from cancer patients after intravenous drip of chemotherapy drugs. One-step solid-phase extraction was successfully applied using an Ostro sample preparation 96-well plate for plasma samples pretreated with acetonitrile containing 0.1% formic acid. Chromatographic separation was achieved on an Atlantis T3-C18 column (2.1 × 100 mm, 3.0 μm) with gradient elution using a mobile phase consisting of acetonitrile and 10 mM ammonium acetate plus 0.1% formic acid in water, and the flow rate was 0.25 mL/min. The Agilent G6410A triple quadrupole liquid chromatography-mass spectrometry system was operated under the multiple reaction monitoring mode with an electrospray ionization in the positive mode. Linear range was 25.0–2500.0 ng for paclitaxel, 10.0–1000.0 ng for docetaxel and SN-38, 100.0–10000.0 ng for vinorelbine and pemetrexed, 10.0–10000.0 ng for vinblastine and irinotecan, 1.0–1000.0 ng for cyclophosphamide and ifosfamide, 50.0–5000.0 ng for carboplatin, etoposide, and gemcitabine. Linearity coefficients of correlation were >0.99 for all analytes. The intraday and interday accuracy and precision of the method were within ±15.0% and less than 15%. The mean recovery and matrix effect as well as stability of all the analytes ranged from 56.2% to 98.9% and 85.2% to 101.3% as well as within ±15.0%. This robust and efficient method was successfully applied to implement therapeutic drug monitoring for cancer patients in clinical application.
format Article
id doaj-art-bf8e856128b74049a3dfed8e76a00ae8
institution Kabale University
issn 2090-8865
2090-8873
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Analytical Methods in Chemistry
spelling doaj-art-bf8e856128b74049a3dfed8e76a00ae82025-02-03T01:25:20ZengWileyJournal of Analytical Methods in Chemistry2090-88652090-88732018-01-01201810.1155/2018/79676947967694One-Step Solid Extraction for Simultaneous Determination of Eleven Commonly Used Anticancer Drugs and One Active Metabolite in Human Plasma by HPLC-MS/MSShouhong Gao0Zhengbo Tao1Jingya Zhou2Zhipeng Wang3Yunlei Yun4Mingming Li5Feng Zhang6Wansheng Chen7Yejun Miao8Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, ChinaDepartment of Orthopaedics, First Affiliated Hospital, China Medical University, 155 Nan Jing Bei Street, Shenyang, Liaoning 110001, ChinaDepartment of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, ChinaDepartment of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, ChinaDepartment of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, ChinaDepartment of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, ChinaDepartment of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, ChinaDepartment of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, ChinaDepartment of Psychiatry, Ankang Hospital, Ningbo, Zhejiang 315000, ChinaTherapeutic drug monitoring for anticancer drugs could timely reflect in vivo drug exposure, and it was a powerful tool for adjusting and maintaining drug concentration into a reasonable range, so that an enhanced efficacy and declined adverse reactions could be achieved. A liquid chromatography-tandem mass spectrometry method had been developed and fully validated for simultaneous determination of paclitaxel, docetaxel, vinblastine, vinorelbine, pemetrexed, carboplatin, etoposide, cyclophosphamide, ifosfamide, gemcitabine, irinotecan, and SN-38 (an active metabolite of irinotecan) in human plasma from cancer patients after intravenous drip of chemotherapy drugs. One-step solid-phase extraction was successfully applied using an Ostro sample preparation 96-well plate for plasma samples pretreated with acetonitrile containing 0.1% formic acid. Chromatographic separation was achieved on an Atlantis T3-C18 column (2.1 × 100 mm, 3.0 μm) with gradient elution using a mobile phase consisting of acetonitrile and 10 mM ammonium acetate plus 0.1% formic acid in water, and the flow rate was 0.25 mL/min. The Agilent G6410A triple quadrupole liquid chromatography-mass spectrometry system was operated under the multiple reaction monitoring mode with an electrospray ionization in the positive mode. Linear range was 25.0–2500.0 ng for paclitaxel, 10.0–1000.0 ng for docetaxel and SN-38, 100.0–10000.0 ng for vinorelbine and pemetrexed, 10.0–10000.0 ng for vinblastine and irinotecan, 1.0–1000.0 ng for cyclophosphamide and ifosfamide, 50.0–5000.0 ng for carboplatin, etoposide, and gemcitabine. Linearity coefficients of correlation were >0.99 for all analytes. The intraday and interday accuracy and precision of the method were within ±15.0% and less than 15%. The mean recovery and matrix effect as well as stability of all the analytes ranged from 56.2% to 98.9% and 85.2% to 101.3% as well as within ±15.0%. This robust and efficient method was successfully applied to implement therapeutic drug monitoring for cancer patients in clinical application.http://dx.doi.org/10.1155/2018/7967694
spellingShingle Shouhong Gao
Zhengbo Tao
Jingya Zhou
Zhipeng Wang
Yunlei Yun
Mingming Li
Feng Zhang
Wansheng Chen
Yejun Miao
One-Step Solid Extraction for Simultaneous Determination of Eleven Commonly Used Anticancer Drugs and One Active Metabolite in Human Plasma by HPLC-MS/MS
Journal of Analytical Methods in Chemistry
title One-Step Solid Extraction for Simultaneous Determination of Eleven Commonly Used Anticancer Drugs and One Active Metabolite in Human Plasma by HPLC-MS/MS
title_full One-Step Solid Extraction for Simultaneous Determination of Eleven Commonly Used Anticancer Drugs and One Active Metabolite in Human Plasma by HPLC-MS/MS
title_fullStr One-Step Solid Extraction for Simultaneous Determination of Eleven Commonly Used Anticancer Drugs and One Active Metabolite in Human Plasma by HPLC-MS/MS
title_full_unstemmed One-Step Solid Extraction for Simultaneous Determination of Eleven Commonly Used Anticancer Drugs and One Active Metabolite in Human Plasma by HPLC-MS/MS
title_short One-Step Solid Extraction for Simultaneous Determination of Eleven Commonly Used Anticancer Drugs and One Active Metabolite in Human Plasma by HPLC-MS/MS
title_sort one step solid extraction for simultaneous determination of eleven commonly used anticancer drugs and one active metabolite in human plasma by hplc ms ms
url http://dx.doi.org/10.1155/2018/7967694
work_keys_str_mv AT shouhonggao onestepsolidextractionforsimultaneousdeterminationofelevencommonlyusedanticancerdrugsandoneactivemetaboliteinhumanplasmabyhplcmsms
AT zhengbotao onestepsolidextractionforsimultaneousdeterminationofelevencommonlyusedanticancerdrugsandoneactivemetaboliteinhumanplasmabyhplcmsms
AT jingyazhou onestepsolidextractionforsimultaneousdeterminationofelevencommonlyusedanticancerdrugsandoneactivemetaboliteinhumanplasmabyhplcmsms
AT zhipengwang onestepsolidextractionforsimultaneousdeterminationofelevencommonlyusedanticancerdrugsandoneactivemetaboliteinhumanplasmabyhplcmsms
AT yunleiyun onestepsolidextractionforsimultaneousdeterminationofelevencommonlyusedanticancerdrugsandoneactivemetaboliteinhumanplasmabyhplcmsms
AT mingmingli onestepsolidextractionforsimultaneousdeterminationofelevencommonlyusedanticancerdrugsandoneactivemetaboliteinhumanplasmabyhplcmsms
AT fengzhang onestepsolidextractionforsimultaneousdeterminationofelevencommonlyusedanticancerdrugsandoneactivemetaboliteinhumanplasmabyhplcmsms
AT wanshengchen onestepsolidextractionforsimultaneousdeterminationofelevencommonlyusedanticancerdrugsandoneactivemetaboliteinhumanplasmabyhplcmsms
AT yejunmiao onestepsolidextractionforsimultaneousdeterminationofelevencommonlyusedanticancerdrugsandoneactivemetaboliteinhumanplasmabyhplcmsms